Quantification of IGF‐1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis

Autor:	Ching Wong, Hui Chen, Vladimir Gotlieb, Preethi Ramachandran, Jen-Chin Wang, Guanfang Shi
Rok vydání:	2019
Předmět:	Adult Male Oncology medicine.medical_specialty Biopsy Logistic regression Peripheral blood mononuclear cell Marker gene Gastroenterology Receptor IGF Type 1 Flow cytometry Diagnosis Differential Bone Marrow Informed consent Internal medicine medicine Humans Receptor Aged Aged 80 and over medicine.diagnostic_test Thrombocytosis business.industry Hematology General Medicine Middle Aged Flow Cytometry medicine.disease medicine.anatomical_structure Female Bone marrow Differential diagnosis business Thrombocythemia Essential
Zdroj:	European Journal of Haematology. 103:573-577
ISSN:	1600-0609 0902-4441
DOI:	10.1111/ejh.13323
Popis:	To make a definite diagnosis of essential thrombocytosis (ET) from reactive thrombocytosis (RT), the most reliable criteria are the presence of driver mutations, namely JAK2, CALR, or MPL gene mutations. In the absence of these driver mutations, so-called triple-negative ET, the differential diagnosis could be difficult; bone marrow biopsy could be helpful, but in some cases it may be difficult, to do gene sequence analysis to find other clonal marker gene mutations than the driver mutations, only very few were found. We studied IGF-1R quantification by flow cytometry in mononuclear cells (MNC) from peripheral blood, a substitute for performing endogenous erythroid colony formation (EEC), in 33 patients with ET (untreated or off treatment with hydroxyurea), 28 patients with RT, and 16 normal volunteer controls. We found IGF-1R levels significantly elevated in ET patients compared to RT patients or controls. A cutoff value of 253 was chosen from the logistic regression to predict each patient's group, a value ≥253 meant that a patient belonged to the ET group (sensitivity of 68.6% and specificity 96.4.%). Therefore, we suggest adding quantification of IGF-1R in blood MNC by flow cytometry is useful in differentiating ET from RT , we suggest this maybe added to the minor criteria for diagnosing ET. Funding Statement: JCW received grants from Celgen Corp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Declaration of Interests: The author declares no conflicting interests with the commercial funder relating to using products, consultancy, patents, product development, or market products. The other authors declare no competing financial interests. Ethics Approval Statement: Peripheral blood was obtained from patients with written informed consent, the protocol for which was approved by the IRB of Brookdale University Hospital.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec63edcbe9a9e2e7c571503e3538023 https://doi.org/10.1111/ejh.13323 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.